Planning
Thursday, November 23, 2017
| Time |
Event |
|
|
09:05 - 09:30
|
Welcome of participants (Pierre Fabre's Center for Research and Development, Auditorium) - Julie GUILLERMET-GUIBERT (Cancer Research Center of Toulouse, Toulouse, France) |
|
|
09:30 - 09:35
|
Introduction from the Directors (Pierre Fabre's Center for Research and Development, Auditorium) - Gilles FAVRE (Cancer Research Center of Toulouse, Toulouse, France), Christian FILAQUIER (Pierre Fabre's Center for R&D, Toulouse, France) |
|
|
09:35 - 10:20
|
mTOR signalling & metabolism (Pierre Fabre's Center for Research and Development, Auditorium) - Arkaitz CARRACEDO (CIC bioGUNE, Bilbao, Spain) |
|
|
10:20 - 11:05
|
p110delta PI3K regulates gut immunity and inflammation by unconventional autophagy (Pierre Fabre's Center for Research and Development, Auditorium) - Ezra AKSOY (William Harvey Institute, London, United Kingdom) |
|
|
11:05 - 11:25
|
Short talk 1 (Pierre Fabre's Center for Research and Development, Auditorium) - To be defined |
|
|
11:25 - 11:55
|
Coffee break (Pierre Fabre's Center for Research and Development, reception lobby) |
|
|
11:55 - 12:15
|
Short talk 2 (Pierre Fabre's Center for Research and Development, Auditorium) - To be defined |
|
|
12:15 - 13:00
|
Synthetic Lethality screening identify ATR to synergize with oxaliplatin treatment in colorectal cancer (Pierre Fabre's Center for Research and Development, Auditorium) - Celine GONGORA (Institute of Cancer Research of Montpellier, Montpellier, France) |
|
|
13:00 - 13:15
|
Participants go to CRCT for lunch & poster session - All participants will be led from the Pierre Fabre's Center for R&D to the CRCT |
|
|
13:15 - 14:30
|
Lunch & Poster session (Cancer Research Center of Toulouse, meeting-room Christophe Cazaux) |
|
|
14:30 - 14:45
|
Participants go to Pierre Fabre's Center for R&D for afternoon conferences - All participants will be led from the CRCT to the Pierre Fabre's Center for R&D |
|
|
14:45 - 15:05
|
Short talk 3 (Pierre Fabre's Center for Research and Development, Auditorium) - To be defined |
|
|
15:05 - 15:25
|
Short talk 4 (Pierre Fabre's Center for Research and Development, Auditorium) - To be defined |
|
|
15:25 - 16:10
|
Loss of PI3K-C2alpha in breast cancer leads to genomic instability but increases Taxane sensitivity (Pierre Fabre's Center for Research and Development, Auditorium) - Emilio HIRSCH (University of Torino, Torino, Italy) |
|
|
16:10 - 16:20
|
Conclusion & take-home messages (Pierre Fabre's Center for Research and Development, Auditorium) - Julie GUILLERMET-GUIBERT (Cancer Research Center of Toulouse, Toulouse, France) |
|
|
